Literature DB >> 17151201

Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis.

Meiling Zhang1, Bianying Liu, Yan Zhang, Hua Wei, Yufeng Lei, Liping Zhao.   

Abstract

To understand the role of mucosa-associated microbiota in the pathogenicity of ulcerative colitis (UC), paired biopsies were obtained during colonoscopy from the ulcerated and nonulcerated gut mucosa of 24 patients with UC. Denaturing gradient gel electrophoresis analysis was employed to profile the composition of the dominant bacteria (16S rRNA gene V3 region) and three important groups: lactobacilli, the Clostridium leptum subgroup, and Bacteroides spp. The Pearson coefficient was used to estimate similarities between the bacterial communities of the paired biopsies for each patient. The average similarity values of bacterial composition between the paired samples were 94.8 +/- 3.8% for dominant bacteria, 59.9 +/- 26.1% for lactobacilli, 79.2 +/- 22.6% for the Clostridium leptum subgroup, and 88.7 +/- 16.4% for Bacteroides spp. The data revealed that lactobacilli and the Clostridium leptum subgroup were significantly different between the ulcerated and the nonulcerated regions. It also was noted that for lactobacilli, the composition varied significantly between biopsy sites irrespective of the location of UC in the gut but that the composition of the Clostridium leptum subgroup showed significant differences between paired samples from UC in the rectum and not in the left colon. Localized dysbiosis of the mucosa-associated intestinal microflora, especially for lactobacilli and the Clostridium leptum subgroup, may be closely related to UC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151201      PMCID: PMC1829069          DOI: 10.1128/JCM.01720-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

Review 1.  The microbiology of butyrate formation in the human colon.

Authors:  Susan E Pryde; Sylvia H Duncan; Georgina L Hold; Colin S Stewart; Harry J Flint
Journal:  FEMS Microbiol Lett       Date:  2002-12-17       Impact factor: 2.742

2.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

Authors:  M P Conte; S Schippa; I Zamboni; M Penta; F Chiarini; L Seganti; J Osborn; P Falconieri; O Borrelli; S Cucchiara
Journal:  Gut       Date:  2006-04-28       Impact factor: 23.059

3.  Molecular profiling of the Clostridium leptum subgroup in human fecal microflora by PCR-denaturing gradient gel electrophoresis and clone library analysis.

Authors:  Jian Shen; Baorang Zhang; Guifang Wei; Xiaoyan Pang; Hua Wei; Min Li; Yan Zhang; Wei Jia; Liping Zhao
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 4.  Virulence factors in anaerobes.

Authors:  B I Duerden
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

Authors:  T Kühbacher; S J Ott; U Helwig; T Mimura; F Rizzello; B Kleessen; P Gionchetti; M Blaut; M Campieri; U R Fölsch; M A Kamm; S Schreiber
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

7.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

8.  The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects.

Authors:  Céline Robert; Annick Bernalier-Donadille
Journal:  FEMS Microbiol Ecol       Date:  2003-10-01       Impact factor: 4.194

9.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

2.  Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India.

Authors:  Ravi Verma; Anil Kumar Verma; Vineet Ahuja; Jaishree Paul
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

Review 3.  Interspecies interactions within oral microbial communities.

Authors:  Howard K Kuramitsu; Xuesong He; Renate Lux; Maxwell H Anderson; Wenyuan Shi
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

4.  Intestinal microbiota in inflammatory bowel disease: friend of foe?

Authors:  Francesca Fava; Silvio Danese
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome.

Authors:  Karine Gloux; Olivier Berteau; Hanane El Oumami; Fabienne Béguet; Marion Leclerc; Joël Doré
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

6.  Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.

Authors:  Jingxiao Ye; Jimmy W Lee; Laura L Presley; Elizabeth Bent; Bo Wei; Jonathan Braun; Neal L Schiller; Daniel S Straus; James Borneman
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

Review 7.  Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.

Authors:  Christopher D Packey; R Balfour Sartor
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

8.  A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

Authors:  Caroline Codling; Liam O'Mahony; Fergus Shanahan; Eamonn M M Quigley; Julian R Marchesi
Journal:  Dig Dis Sci       Date:  2009-08-20       Impact factor: 3.199

Review 9.  Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.

Authors:  Saurabh Kedia; Ritika Rampal; Jaishree Paul; Vineet Ahuja
Journal:  J Gastroenterol       Date:  2016-03-19       Impact factor: 7.527

10.  Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2.

Authors:  M Schlee; J Harder; B Köten; E F Stange; J Wehkamp; K Fellermann
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.